Literature DB >> 28004176

Overlapping implantation of bioresorbable novolimus-eluting scaffolds: an observational optical coherence tomography study.

Florian Blachutzik1, Niklas Boeder2, Jens Wiebe3, Alessio Mattesini4, Oliver Dörr2, Astrid Most2, Timm Bauer2, Monique Tröbs5, Jens Röther5, Christian Schlundt5, Stephan Achenbach5, Christian Hamm2, Holger Nef2.   

Abstract

Overlapping implantation of bioresorbable vascular scaffolds is frequently necessary, but its influence on vessel and scaffold structure has not been thoroughly analyzed previously. The aim of this study was to analyze the acute effects of overlapping implantation on BRS as determined by optical coherence tomography (OCT). A total of 38 patients with de novo coronary artery stenoses who underwent OCT in the context of implantation of novolimus-eluting BRS (DESolve, Elixir Medical Corporation, Sunnyvale, California, USA) were investigated. In 15 patients, overlapping implantation of two BRS was performed, while 23 patients with implantation of one single BRS served as the control group. OCT data were retrospectively analyzed regarding acute scaffold implantation results. There were no significant differences between the overlap and control group in terms of residual in-scaffold area stenosis, scaffold area, mean or minimal lumen area, eccentricity index, incomplete scaffold apposition area or malapposition. While strut fracture was slightly more frequent in BRS with overlap its incidence was low overall. In patients with overlapping BRS, overlap segments did not display smaller lumen areas than segments without overlap (mean lumen area overlap: 8.16 ± 2.97 mm2 vs. no overlap: 7.70 ± 2.55 mm2; p = 0.71; minimal lumen area overlap: 6.83 ± 2.71 mm2 vs. no overlap: 6.17 ± 2.58 mm2; p = 0.37). Acute mechanical performance of novolimus-eluting BRS is not impaired by overlapping implantation. It can be assumed that vessel expansion compensates for the double scaffold layer in the overlap area resulting in a similar lumen area in overlap areas and in those with a single strut layer.

Entities:  

Keywords:  Bioresorbable Scaffold; Optical coherence tomography; Percutaneous coronary intervention

Mesh:

Substances:

Year:  2016        PMID: 28004176     DOI: 10.1007/s00380-016-0932-9

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  24 in total

1.  Bioresorbable vascular scaffold overlap evaluation with optical coherence tomography after implantation with or without enhanced stent visualization system (WOLFIE study): a two-centre prospective comparison.

Authors:  Simone Biscaglia; Gianluca Campo; Matteo Tebaldi; Carlo Tumscitz; Rita Pavasini; Luca Fileti; Gioel G Secco; Carlo Di Mario; Roberto Ferrari
Journal:  Int J Cardiovasc Imaging       Date:  2015-09-01       Impact factor: 2.357

2.  Periprocedural and late consequences of overlapping Cypher sirolimus-eluting stents: pooled analysis of five clinical trials.

Authors:  Dean J Kereiakes; Hong Wang; Jeffrey J Popma; Richard E Kuntz; Dennis J Donohoe; Joachim Schofer; Erick Schampaert; Bernhard Meier; Martin B Leon; Jeffrey W Moses
Journal:  J Am Coll Cardiol       Date:  2006-06-12       Impact factor: 24.094

3.  Neointimal coverage and late apposition of everolimus-eluting bioresorbable scaffolds implanted in the acute phase of myocardial infarction: OCT data from the PRAGUE-19 study.

Authors:  Petr Toušek; Viktor Kočka; Martin Malý; Libor Lisa; Tomáš Buděšínský; Petr Widimský
Journal:  Heart Vessels       Date:  2015-04-21       Impact factor: 2.037

4.  Contemporary practice and technical aspects in coronary intervention with bioresorbable scaffolds: a European perspective.

Authors:  Corrado Tamburino; Azeem Latib; Robert-Jan van Geuns; Manel Sabate; Julinda Mehilli; Tommaso Gori; Stephan Achenbach; Manuel Pan Alvarez; Holger Nef; Maciej Lesiak; Carlo Di Mario; Antonio Colombo; Christoph K Naber; Giuseppe Caramanno; Piera Capranzano; Salvatore Brugaletta; Salvatore Geraci; Aleksander Araszkiewicz; Alessio Mattesini; Stylianos A Pyxaras; Lukasz Rzeszutko; Rafalo Depukat; Roberto Diletti; Els Boone; Davide Capodanno; Dariusz Dudek
Journal:  EuroIntervention       Date:  2015-05       Impact factor: 6.534

5.  Absorb vs. DESolve: an optical coherence tomography comparison of acute mechanical performances.

Authors:  Alessio Mattesini; Niklas Boeder; Serafina Valente; Katja Löblich; Oliver Dörr; Gioel G Secco; Nicolas Foin; Gianluca Caiazzo; Matteo Ghione; Gian Franco Gensini; Italo Porto; Carlo Di Mario; Holger Nef
Journal:  EuroIntervention       Date:  2016-08-05       Impact factor: 6.534

6.  A next-generation bioresorbable coronary scaffold system: from bench to first clinical evaluation: 6- and 12-month clinical and multimodality imaging results.

Authors:  Stefan Verheye; John A Ormiston; James Stewart; Mark Webster; Elias Sanidas; Ricardo Costa; J Ribamar Costa; Daniel Chamie; Andrea S Abizaid; Ibraim Pinto; Lynn Morrison; Sara Toyloy; Vinayak Bhat; John Yan; Alexandre Abizaid
Journal:  JACC Cardiovasc Interv       Date:  2013-10-16       Impact factor: 11.195

7.  Relation Between Bioresorbable Scaffold Sizing Using QCA-Dmax and Clinical Outcomes at 1 Year in 1,232 Patients From 3 Study Cohorts (ABSORB Cohort B, ABSORB EXTEND, and ABSORB II).

Authors:  Yuki Ishibashi; Shimpei Nakatani; Yohei Sotomi; Pannipa Suwannasom; Maik J Grundeken; Hector M Garcia-Garcia; Antonio L Bartorelli; Robert Whitbourn; Bernard Chevalier; Alexandre Abizaid; John A Ormiston; Richard J Rapoza; Susan Veldhof; Yoshinobu Onuma; Patrick W Serruys
Journal:  JACC Cardiovasc Interv       Date:  2015-11       Impact factor: 11.195

8.  Appropriate use of bioresorbable vascular scaffolds in percutaneous coronary interventions: a recommendation from experienced users : A position statement on the use of bioresorbable vascular scaffolds in the Netherlands.

Authors:  Bert Everaert; Cordula Felix; Jacques Koolen; Peter den Heijer; Jose Henriques; Joanna Wykrzykowska; Rene van der Schaaf; Bart de Smet; Sjoerd Hofma; Roberto Diletti; Nicolas Van Mieghem; Evelyn Regar; Peter Smits; Robert-Jan M van Geuns
Journal:  Neth Heart J       Date:  2015-03       Impact factor: 2.380

9.  Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction-TROFI II trial.

Authors:  Manel Sabaté; Stephan Windecker; Andres Iñiguez; Lisette Okkels-Jensen; Angel Cequier; Salvatore Brugaletta; Sjoerd H Hofma; Lorenz Räber; Evald Høi Christiansen; Maarten Suttorp; Thomas Pilgrim; Gerrit Anne van Es; Yohei Sotomi; Hector M García-García; Yoshinobu Onuma; Patrick W Serruys
Journal:  Eur Heart J       Date:  2015-09-23       Impact factor: 29.983

10.  A randomized trial evaluating everolimus-eluting Absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB Japan.

Authors:  Takeshi Kimura; Ken Kozuma; Kengo Tanabe; Sunao Nakamura; Masahisa Yamane; Toshiya Muramatsu; Shigeru Saito; Junji Yajima; Nobuhisa Hagiwara; Kazuaki Mitsudo; Jeffrey J Popma; Patrick W Serruys; Yoshinobu Onuma; Shihwa Ying; Sherry Cao; Peter Staehr; Wai-Fung Cheong; Hajime Kusano; Gregg W Stone
Journal:  Eur Heart J       Date:  2015-09-01       Impact factor: 29.983

View more
  3 in total

Review 1.  BRS implantation in long lesions requiring device overlapping: myth or reality?

Authors:  Simone Biscaglia; Andrea Erriquez; Davide Bernucci; Giulia Bugani; Enrico Favaretto; Gianluca Campo
Journal:  J Thorac Dis       Date:  2017-08       Impact factor: 2.895

Review 2.  The DESolve novolimus bioresorbable Scaffold: from bench to bedside.

Authors:  Alessio Mattesini; Simone Bartolini; Carlotta Sorini Dini; Serafina Valente; Guido Parodi; Miroslava Stolcova; Francesco Meucci; Carlo Di Mario
Journal:  J Thorac Dis       Date:  2017-08       Impact factor: 2.895

3.  Long-term results of long segment coronary artery lesions overlapped with novolimus-eluting DESolve scaffold: Disappointment or futuristic?

Authors:  Ersin İbişoğlu; Sinem Çakal; Beytullah Çakal; H Murat Güneş; Bedrettin Boyraz; Bilal Boztosun
Journal:  Anatol J Cardiol       Date:  2021-12       Impact factor: 1.596

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.